Note 13 – Subsequent Events

On July 1, 2026, the remaining 400,000 Pre-Funded Warrants from the Private Placement completed during May 2026 were exercised.

On July 30, 2026, the Company entered into an inducement agreement with certain holders of certain of the Company’s existing warrants to purchase up to an aggregate of 1,702,362 shares of the Company’s common stock originally issued on May 21, 2026, with a five-5year term at an exercise price of $1.571 per share.

Pursuant to the agreement, the warrant holders agreed to exercise for cash the existing warrants to purchase an aggregate of 1,702,362 shares of the Company’s common stock at an exercise price of $1.571 per share in consideration of the Company’s agreement to issue additional new common stock purchase warrants to purchase up to an aggregate of 3,404,724 shares of the Company’s common stock at an exercise price of $1.56 per share. These new warrants are not exercisable until the Company obtains stockholder approval of the exercise. The Company received aggregate gross proceeds of approximately $2.67 million from the exercise of the existing warrants, before deducting placement agent fees and other offering expenses payable by the Company. The Company agreed to pay Maxim (i) a cash fee equal to 7.0% of the aggregate gross proceeds received from the exercise of the existing warrants and (ii) reimbursement of the Maxim’s reasonable expenses, including without limitation, fees and disbursements of the Maxim’s counsel, incurred in connection with the transactions contemplated by the inducement agreement in an amount equal to $50,000.